Methods of treating bacterial infections using oritavancin

Details for Australian Patent Application No. 2010245097 (hide)

Owner Targanta Therapeutics Corp.

Inventors McKay, Geoffrey; Beaulieu, Sylvain; Lehoux, Dario; Parr Jr., Thomas; Moeck, Gregory

Agent Davies Collison Cave

Pub. Number AU-A-2010245097

PCT Pub. Number WO2010/129233

Priority 61/173,451 28.04.09 US

Filing date 26 April 2010

Wipo publication date 11 November 2010

International Classifications

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12P 17/16 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing two or more hetero rings

C12Q 1/18 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Testing for antimicrobial activity of a material

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/129233 Priority application(s): WO2010/129233

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010245098-CNT-based resistive heating for deicing composite structures

2010245082-Track shoe assembly for continuous track vehicles